Diabetes Prevention Education Program in a population with pre-diabetes in Nepal: a study protocol of a cluster randomised controlled trial (DiPEP)

Pushpanjali Shakya, Archana Shrestha, Biraj Man Karmacharya, Abha Shrestha, Bård Eirik Kulseng, Eva Skovlund, Abhijit Sen, Pushpanjali Shakya, Archana Shrestha, Biraj Man Karmacharya, Abha Shrestha, Bård Eirik Kulseng, Eva Skovlund, Abhijit Sen

Abstract

Introduction: Evidence suggests that diabetes burden can be reduced by implementing early lifestyle intervention programmes in population with pre-diabetes in high-income countries. However, little is known in developing nations like Nepal. This study aims to assess effectiveness of community-based Diabetes Prevention Education Program (DiPEP) on haemoglobin A1c (HbA1c) level, proportion of pre-diabetes reverting to normoglycaemia, diet, physical activity, weight reduction, diabetes knowledge and health literacy after 6 months of follow-up. Furthermore, we will also conduct qualitative studies to explore experiences of participants of intervention sessions and perception of healthcare workers/volunteers about DiPEP.

Methods and analyses: This is a community-based two-arm, open-label, cluster randomised controlled trial. We will randomise 14 clusters into intervention arm and control arm. Estimated total sample size is 448. We will screen individuals without diabetes, aged 18-64 years, and permanent residents of study sites. HbA1c test will be only performed if both Indian Diabetes Risk Score and random blood sugar value are ≥60 and 140-250 mg/dL, respectively. At baseline, participants in intervention arm will receive DiPEP package (including intensive intervention classes, diabetes prevention brochure, exercise calendar and food record booklet), and participants in control arm will be provided only with diabetes prevention brochure. The change in outcome measures will be compared between intervention to control arm after 6 months of follow-up by linear mixed models. Also, we will conduct individual interviews among participants and healthcare workers as part of a qualitative study. We will use thematic analysis to analyse qualitative data.

Ethics and dissemination: Regional Committee for Medical and Health Research Ethics, Norway; Nepal Health Research Council, Nepal and Institutional Review Committee, Kathmandu University School of Medical Sciences have approved the study. The DiPEP package can be implemented in other communities of Nepal if it is effective in preventing diabetes.

Trial registration number: NCT04074148, 2019/783.

Keywords: diabetes & endocrinology; education & training (see medical education & training); general diabetes; preventive medicine; public health.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Consort diagram. This figure illustrates the study design (RCT). A total of 448 participants with pre-diabetes will be randomised to an intervention arm and a control arm. RCT, randomised controlled trial.

References

    1. Diabetes [online]. Available: [Accessed 6 Aug 2020].
    1. Facts & figures [online]. Available: [Accessed 6 Apr 2021].
    1. Gyawali B, Sharma R, Neupane D, et al. . Prevalence of type 2 diabetes in Nepal: a systematic review and meta-analysis from 2000 to 2014. Glob Health Action 2015;8. 10.3402/gha.v8.29088. [Epub ahead of print: Available from].
    1. Zhang X, Saaddine JB, Chou C-F, et al. . Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304:649. 10.1001/jama.2010.1111
    1. ADA . Standards of medical care in diabetes-2020. J Clin Appl Res Educat Diabet Care 2020;43
    1. Huang D, Refaat M, Mohammedi K, et al. . Macrovascular complications in patients with diabetes and prediabetes. Biomed Res Int 2017;2017:7839101 10.1155/2017/7839101
    1. Zhang X, Saaddine JB, Chou C-F, et al. . Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304:649–56. 10.1001/jama.2010.1111
    1. International diabetes federation - facts & figures [online]. Available: [Accessed 12 Mar 2020].
    1. International diabetes federation - facts & figures [online]. Available: [Accessed 12 Mar 2020].
    1. Tabák AG, Herder C, Rathmann W, et al. . Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279–90. 10.1016/S0140-6736(12)60283-9
    1. Glechner A, Keuchel L, Affengruber L, et al. . Effects of lifestyle changes on adults with prediabetes: a systematic review and meta-analysis. Prim Care Diabetes 2018;12:393–408. 10.1016/j.pcd.2018.07.003
    1. Department of Health, New York State . Prediabetes [online]. Available: [Accessed 29 Apr 2019].
    1. Hostalek U. Global epidemiology of prediabetes - present and future perspectives. Clin Diabetes Endocrinol 2019;510.1186/s40842-019-0080-0
    1. Huang D, Refaat M, Mohammedi K. Macrovascular complications in patients with diabetes and prediabetes. Biomed Res Int 2017;2017:1–9. 10.1155/2017/7839101
    1. Kopf S, Groener JB, Kender Z, et al. . Deep phenotyping neuropathy: an underestimated complication in patients with pre-diabetes and type 2 diabetes associated with albuminuria. Diabetes Res Clin Pract 2018;146:201 10.1016/j.diabres.2018.10.020
    1. Perreault L, Pan Q, Mather KJ, et al. . Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the diabetes prevention program outcomes study. Lancet 2012;379:2243–51. 10.1016/S0140-6736(12)60525-X
    1. Ramachandran A, Snehalatha C, Mary S, et al. . The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289–97. 10.1007/s00125-005-0097-z
    1. A glimpse of dhulikhel municipality [online]. Available: [Accessed 23 Apr 2019].
    1. Statistical Information | Lalitpur Metropolitan City [online]. Available: [Accessed 24 Mar 2020].
    1. Shrestha A, Tamrakar D, Karmacharya BM, et al. . Nepal pioneer worksite intervention study to lower cardio-metabolic risk factors: design and protocol. BMC Cardiovasc Disord 2019;19:48. 10.1186/s12872-019-1025-3
    1. Lorenz E, Köpke S, Pfaff H. Cluster-randomized studies: part 25 of a series on evaluating scientific publications. Deutsches Ärzteblatt International 2018;115:163.
    1. Guest G, Bunce A, Johnson L. How many interviews are enough? Field Methods 2006;18:59–82. 10.1177/1525822X05279903
    1. Mohan V, Deepa R, Deepa M, et al. . A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India 2005;53:53–63.
    1. Heinemann L, Freckmann G, Lutz Heinemann GF. Quality of HbA1c measurement in the practice: the German perspective. J Diabetes Sci Technol 2015;9:687. 10.1177/1932296815572254
    1. Leca V, Ibrahim Z, Lombard-Pontou E, et al. . Point-of-care measurements of HbA(1c): simplicity does not mean laxity with controls. Diabetes Care 2012;35:e85. 10.2337/dc12-0751
    1. American Diabetes Association . Classification and diagnosis of diabetes: standards of medical care in Diabetes—2019. Diabetes Care 2019;42.
    1. WHO . Global physical activity questionnaire (GPAQ) analysis guide [online]. Available:
    1. Eigenmann CA, Skinner T, Colagiuri R. Development and validation of a diabetes knowledge questionnaire. Practical Diabetes International 2011;28:166–70. 10.1002/pdi.1586
    1. Ishikawa H, Takeuchi T, Yano E. Measuring functional, communicative, and critical health literacy among diabetic patients. Diabetes Care 2008;31:874–9. 10.2337/dc07-1932
    1. Pickering TG, Hall JE, Appel LJ, et al. . Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on high blood pressure research professional and public education Subcommittee. J Clin Hypertens 2005;7:102–9. 10.1111/j.1524-6175.2005.04377.x
    1. The health belief model [online]. Available: [Accessed 12 Aug 2019].
    1. The social cognitive theory [online]. Available: [Accessed 12 Aug 2019].
    1. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 10.4278/0890-1171-12.1.38
    1. Diabetes Prevention Program (DPP) Research Group . The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care 2002;25:2165–71. 10.2337/diacare.25.12.2165
    1. Brinkmaan S, Kvale S, eds. Preparing for interview analysis. In: InterViews. California: SAGE publications, Inc, 2015.
    1. Modesti PA, Galanti G, Cala' P, et al. . Lifestyle interventions in preventing new type 2 diabetes in Asian populations. Intern Emerg Med 2016;11:375–84. 10.1007/s11739-015-1325-2
    1. Andersen PK. Design and analysis of cluster randomization trials in health research. Stat Med 2002;21. 10.1002/sim.957
    1. Eldridge S, Kerry S, Torgerson DJ. Bias in identifying and recruiting participants in cluster randomised trials: what can be done? BMJ 2009;339:b4006. 10.1136/bmj.b4006
    1. Torgerson DJ. Contamination in trials: is cluster randomisation the answer? BMJ 2001;322:355–7. 10.1136/bmj.322.7282.355
    1. van Breukelen GJP, Candel MJJM. Calculating sample sizes for cluster randomized trials: we can keep it simple and efficient! J Clin Epidemiol 2012;65:1212–8. 10.1016/j.jclinepi.2012.06.002
    1. Campbell MK, Grimshaw JM. Cluster randomised trials: time for improvement. The implications of adopting a cluster design are still largely being ignored. BMJ 1998;317:1171–2. 10.1136/bmj.317.7167.1171
    1. Standards of medical care in diabetesd 2019. Available: [Accessed 21 Apr 2020].

Source: PubMed

3
購読する